Health-care companies fell as traders continued to rotate out of the sector.
UnitedHealth Group, the largest U.S. insurer by enrollees, plans to stop requiring doctors to get approvals for an array of pediatric procedures, tests and services, further cutting back on a process that has long been detested by physicians and patients.
Shares of biotech firm Replimune Group leapt after it reached an agreement with the Food and Drug Administration to resubmit its application for an advanced melanoma treatment following a knockback from the agency in April.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
